CYP21A2 (Gene)

Organism:

Homo sapiens

Synonyms:CA21H, CAH1, CPS1, CYP21, CYP21A2, CYP21B, ENTREZ:1589, HGNC:2600, MIM:613815, NM_000500, NM_001128590, NM_001368143, NM_001368144, NP_000491, NP_001122062, NP_001355072, NP_001355073, P450c21B, XM_024452555, XP_024308323, cytochrome P450 family 21 subfamily A member 2

Omim:OMIM:613815

Id:00553e51-dbfc-5a59-b541-8d7f6f8158e4

Hgnc:HGNC:2600

Entrez:1589

Ensembl:ENSG00000231852

Description:cytochrome P450 family 21 subfamily A member 2

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CYP21A2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CYP21A2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CYP21A2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CYP21A2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CYP21A2.

Results found

Linked to

	Label	Description
	GSE111247 temozolomide LN-308 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 6 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 2 V 7 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE152699 GSE152723 vemurafenib 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE144843 GSE144844 SMARCA2 SMARCA4 knockdown 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 6 V 10 NICOTINAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE192710 ZIC2 ZNF423 inhibition stem cell 4 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 10 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE178292 melphalan 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE111247 temozolomide LN-308 2 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 nicotinamide 6 v 10 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE111247 2 V 7 TEMOZOLOMIDE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE201309 matrine 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE152699 GSE152723 vemurafenib 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE144843 GSE144844 SMARCA2 SMARCA4 knockdown 5 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 6 V 10 NICOTINAMIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE192710 ZIC2 ZNF423 inhibition stem cell 4 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 cisplatin 10 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE178292 melphalan 0 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.